A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer

© 2024 The Authors. Published by American Chemical Society..

Skin cancer (SC) poses a global threat to the healthcare system and is expected to increase significantly over the next two decades if not diagnosed at an early stage. Early diagnosis is crucial for successful treatment, as the disease becomes more challenging to cure as it progresses. However, identifying new drugs, achieving clinical success, and overcoming drug resistance remain significant challenges. To overcome these obstacles and provide effective treatment, it is crucial to understand the causes of skin cancer, how cells grow and divide, factors that affect cell growth, and how drug resistance occurs. In this review, we have explained various therapeutic approaches for SC treatment via ligands, targeted photosensitizers, natural and synthetic drugs for the treatment of SC, an epigenetic approach for management of melanoma, photodynamic therapy, and targeted therapy for BRAF-mutated melanoma. This article also provides a detailed summary of the various natural drugs that are effective in managing melanoma and reducing the occurrence of skin cancer at early stages and focuses on the current status and future prospects of various therapies available for the management of skin cancer.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

ACS omega - 9(2024), 9 vom: 05. März, Seite 10030-10048

Sprache:

Englisch

Beteiligte Personen:

Dachani, Sudharshan Reddy [VerfasserIn]
Kaleem, Mohammed [VerfasserIn]
Mujtaba, Md Ali [VerfasserIn]
Mahajan, Nilesh [VerfasserIn]
Ali, Sayyed A [VerfasserIn]
Almutairy, Ali F [VerfasserIn]
Mahmood, Danish [VerfasserIn]
Anwer, Md Khalid [VerfasserIn]
Ali, Mohammad Daud [VerfasserIn]
Kumar, Sanjay [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Review

Anmerkungen:

Date Revised 12.03.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1021/acsomega.3c09780

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369529790